PATENT CLAIM ANALYSIS

Application Number: 15922674
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["546", "122000"]

Abstract:
A compound of formula (I): being 4-(3-Fluoro-3-(2-(5, 6, 7, 8-tetrahydro-1, 8-naphthyridin-2-yl) ethyl) pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy) phenyl) butanoic acid, or a salt thereof.

Claim (Index 23):
The method according to  claim 17 , wherein the therapeutically active agent is nintedanib.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 1.45161
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16087320', '15514399', '15514407', '15514414', '15514416']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8303298241486077
- 35 USC 102 Novelty (BERT): 0.57236666455506
- Combined Prediction Score: 0.8045335081892528
- Mean Citation Score: 480.40855199999993
- Max Citation Score: 492.16776
- Similarity Product: 361.6837302714872

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test